444 related articles for article (PubMed ID: 11718209)
1. Low doses and thresholds in genotoxicity: from theories to experiments.
Zito R
J Exp Clin Cancer Res; 2001 Sep; 20(3):315-25. PubMed ID: 11718209
[TBL] [Abstract][Full Text] [Related]
2. Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective.
Bolt HM; Foth H; Hengstler JG; Degen GH
Toxicol Lett; 2004 Jun; 151(1):29-41. PubMed ID: 15177638
[TBL] [Abstract][Full Text] [Related]
3. In vivo Comet assay on isolated kidney cells to distinguish genotoxic carcinogens from epigenetic carcinogens or cytotoxic compounds.
Nesslany F; Zennouche N; Simar-Meintières S; Talahari I; Nkili-Mboui EN; Marzin D
Mutat Res; 2007 Jun; 630(1-2):28-41. PubMed ID: 17507283
[TBL] [Abstract][Full Text] [Related]
4. Human carcinogenic risk evaluation, part II: contributions of the EUROTOX specialty section for carcinogenesis.
Bolt HM; Degen GH
Toxicol Sci; 2004 Sep; 81(1):3-6. PubMed ID: 15159528
[TBL] [Abstract][Full Text] [Related]
5. Hormesis and dose-response-mediated mechanisms in carcinogenesis: evidence for a threshold in carcinogenicity of non-genotoxic carcinogens.
Fukushima S; Kinoshita A; Puatanachokchai R; Kushida M; Wanibuchi H; Morimura K
Carcinogenesis; 2005 Nov; 26(11):1835-45. PubMed ID: 15975961
[TBL] [Abstract][Full Text] [Related]
6. Use of DNA adducts to identify human health risk from exposure to hazardous environmental pollutants: the increasing role of mass spectrometry in assessing biologically effective doses of genotoxic carcinogens.
Farmer PB; Singh R
Mutat Res; 2008; 659(1-2):68-76. PubMed ID: 18468947
[TBL] [Abstract][Full Text] [Related]
7. A review of the toxicology of acrylamide.
Exon JH
J Toxicol Environ Health B Crit Rev; 2006; 9(5):397-412. PubMed ID: 17492525
[TBL] [Abstract][Full Text] [Related]
8. [Prevention of cancer and the dose-effect relationship: the carcinogenic effects of ionizing radiations].
Tubiana M
Cancer Radiother; 2009 Jul; 13(4):238-58. PubMed ID: 19539515
[TBL] [Abstract][Full Text] [Related]
9. Do dose response thresholds exist for genotoxic alkylating agents?
Jenkins GJ; Doak SH; Johnson GE; Quick E; Waters EM; Parry JM
Mutagenesis; 2005 Nov; 20(6):389-98. PubMed ID: 16135536
[TBL] [Abstract][Full Text] [Related]
10. Genotoxic thresholds, DNA repair, and susceptibility in human populations.
Jenkins GJ; Zaïr Z; Johnson GE; Doak SH
Toxicology; 2010 Dec; 278(3):305-10. PubMed ID: 19932733
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of non-genotoxic carcinogens and importance of a weight of evidence approach.
Hernández LG; van Steeg H; Luijten M; van Benthem J
Mutat Res; 2009; 682(2-3):94-109. PubMed ID: 19631282
[TBL] [Abstract][Full Text] [Related]
12. Risk assessment of chemical carcinogens and thresholds.
Neumann HG
Crit Rev Toxicol; 2009; 39(6):449-61. PubMed ID: 19545196
[TBL] [Abstract][Full Text] [Related]
13. Nongenotoxic (epigenetic) carcinogens: pesticides as an example. A critical review.
Rakitsky VN; Koblyakov VA; Turusov VS
Teratog Carcinog Mutagen; 2000; 20(4):229-40. PubMed ID: 10910473
[TBL] [Abstract][Full Text] [Related]
14. Approaches to the risk assessment of genotoxic carcinogens in food: a critical appraisal.
O'Brien J; Renwick AG; Constable A; Dybing E; Müller DJ; Schlatter J; Slob W; Tueting W; van Benthem J; Williams GM; Wolfreys A
Food Chem Toxicol; 2006 Oct; 44(10):1613-35. PubMed ID: 16887251
[TBL] [Abstract][Full Text] [Related]
15. Genotoxicity of environmental agents assessed by the alkaline comet assay.
Møller P
Basic Clin Pharmacol Toxicol; 2005; 96 Suppl 1():1-42. PubMed ID: 15859009
[TBL] [Abstract][Full Text] [Related]
16. Addressing nonlinearity in the exposure-response relationship for a genotoxic carcinogen: cancer potency estimates for ethylene oxide.
Kirman CR; Sweeney LM; Teta MJ; Sielken RL; Valdez-Flores C; Albertini RJ; Gargas ML
Risk Anal; 2004 Oct; 24(5):1165-83. PubMed ID: 15563286
[TBL] [Abstract][Full Text] [Related]
17. Implications of arsenic genotoxicity for dose response of carcinogenic effects.
Rudel R; Slayton TM; Beck BD
Regul Toxicol Pharmacol; 1996 Apr; 23(2):87-105. PubMed ID: 8661328
[TBL] [Abstract][Full Text] [Related]
18. Differences in DNA damage and repair produced by systemic, hepatocarcinogenic and sarcomagenic dibenzocarbazole derivatives in a model of rat liver progenitor cells.
Valovicová Z; Marvanová S; Mészárosová M; Srancíková A; Trilecová L; Milcová A; Líbalová H; Vondrácek J; Machala M; Topinka J; Gábelová A
Mutat Res; 2009 Jun; 665(1-2):51-60. PubMed ID: 19427511
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the genotoxic and carcinogenic risks of p-nitrophenol when it is present as an impurity in a drug product.
Eichenbaum G; Johnson M; Kirkland D; O'Neill P; Stellar S; Bielawne J; DeWire R; Areia D; Bryant S; Weiner S; Desai-Krieger D; Guzzie-Peck P; Evans DC; Tonelli A
Regul Toxicol Pharmacol; 2009 Oct; 55(1):33-42. PubMed ID: 19500632
[TBL] [Abstract][Full Text] [Related]
20. Challenging dogma: thresholds for genotoxic carcinogens? The case of vinyl acetate.
Hengstler JG; Bogdanffy MS; Bolt HM; Oesch F
Annu Rev Pharmacol Toxicol; 2003; 43():485-520. PubMed ID: 12415124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
